Natural antibody-induced intracellular signalling and growth control in C3H 10T 1/2 fibroblast variants

Immunology

Volumn 101, Issue 4, 2000, Pages 458-466

  Wang, H ^a   Chow, D A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIBODY; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; GROWTH REGULATION; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TEMPERATURE DEPENDENCE;

ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIVISION; FIBROBLASTS; IMMUNITY, NATURAL; LIPOPROTEINS; MALE; MICE; MICE, INBRED C3H; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TEMPERATURE; TETRADECANOYLPHORBOL ACETATE;

EID: 0034533762     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00131.x     Document Type: Article

References (31)

1. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages
2. Specific IgG autoantibodies are potent inhibitors of autoreactive T cell response to phytohemagglutinin-activated T cells
3. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin
4. Evidence for immunosuppression by high dose gammaglobulin
5. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro
6. Immunomodulation and remyelination: Two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies?
7. Normal human polyspecific immunoglobulin G (intravenous immunoglobulin) modulates endothelial cell function in vitro
8. Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice
9. Reduced tumorigenicity of threshold syngeneic tumor inocula in xid-bearing mice treated with natural antibodies
10. Natural antibody recognition of v-H-ras-induced 10T1/2 transformation
11. Protein kinase C expression links natural antibody binding with surveillance of activated and preneoplastic cells
12. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression
13. Polyclonal natural antitumor antibody binding dynamics: Preferential release of surface membrane molecules and increased metastasis
14. Tumor progression in vitro: Tumorpromotor-induced reversible decrease in natural immune susceptibility
15. Disturbances in growth control and gene expression in a C3H/10T 1/2 cell line that stably overproduces protein kinase C
16. Short-term culture of surfacebiotinylated cells: Application in non-radioactive analysis of surface protein shedding
17. Phorbol ester tumor promoter regulation of natural antitumor antibody binding depends on protein kinase C and an intact microfilament system
18. 2+-dependent protein kinase in human breast cancer cells
19. The receptor-like proteintyrosine phosphatase, RPTP alpha, is phosphorylated by protein kinase C on two serines close to the inner face of the plasma membrane
20. Multiple forms of the human tyrosine phosphatase RPTPα Isozymes and differences in glycosylation
21. Regulation of the src protein tyrosine kinase
22. Stimulation of receptor protein-tyrosine phosphatase alpha activity and phosphorylation by phorbol ester
23. Cell transformation and activation of pp60(c-src) by overexpression of a protein tyrosine phosphatase
24. Receptor protein-tyrosine phosphatase activates pp60(c-src) and is involved in neuronal differentiation
25. Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells
26. Phosphorylation of receptor protein-tyrosine phosphatase α on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo
27. Autocrine regulation of murine B lymphocyte growth by an IgM antibody
28. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG
29. The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids
30. Linking protein kinase C to cell-cycle control
31. Therapeutic preparations of polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: A novel mechanism of action of IVIg involving the FAS apoptotic pathway